How effective is Mycophenolate Mofetil for Kidney Transplant Rejection? (a real world drug study)
Summary:
Overall ratings: 4.3/5 Long term ratings: 4.3/5
This is a phase IV clinical study of how effective Mycophenolate mofetil (mycophenolate mofetil) is for Kidney transplant rejection and for what kind of people. The study is created by eHealthMe from 4 Mycophenolate mofetil users and is updated continuously.
What is Mycophenolate mofetil?
Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,461 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.
What is Kidney transplant rejection?
Kidney transplant rejection is found to be associated with 370 drugs and 483 conditions by eHealthMe. Check the latest studies of Kidney transplant rejection.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
4 people are studied for taking Mycophenolate mofetil in Kidney transplant rejection
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Mycophenolate mofetil effectiveness for Kidney transplant rejection (number of people):
Overall:
- not at all: 0
- somewhat: 0
- moderate: 0
- high: 3
- very high: 1
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 0
- high: 3
- very high: 1
Gender of people who take Mycophenolate mofetil for Kidney transplant rejection *:
- female: 50 %
- male: 50 %
Age of people who take Mycophenolate mofetil for Kidney transplant rejection *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 50 %
- 40-49: 25 %
- 50-59: 25 %
- 60+: 0.0 %
Who find Mycophenolate Mofetil more effective for Kidney Transplant Rejection?
Gender of people who take Mycophenolate mofetil for Kidney transplant rejection *:
- female: 50 %
- male: 50 %
Age of people who take Mycophenolate mofetil for Kidney transplant rejection *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 50 %
- 40-49: 25 %
- 50-59: 25 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Mycophenolate mofetil?
- You can start a phase IV clinical trial to monitor Mycophenolate mofetil safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Mycophenolate mofetil (93,461 reports)
Treatments, associated drugs and conditions:
- Kidney transplant rejection (7,852 reports)
How the study uses the data?
The study is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zofran cause Torsade De Pointes? - 9 seconds ago
- Hawthorn vs. Isradipine, side effect and effectiveness comparison - 10 seconds ago
- Could Venlafaxine Hydrochloride cause Osteoarthritis Aggravated? - 23 seconds ago
- Could Loraz cause Blood Electrolytes Increased? - 36 seconds ago
- Could Zoloft cause Circulatory Collapse? - 40 seconds ago
- Could Baraclude cause Blood Creatine Phosphokinase Increased? - 42 seconds ago
- Could Fluoxetine Hydrochloride cause Oropharyngeal Pain? - 50 seconds ago
- Yaz vs. Gabapentin, side effect and effectiveness comparison - a minute ago
- Tivicay vs. Lexiva, side effect and effectiveness comparison - a minute ago
- Could Diazepam cause Pulpitis Dental? - a minute ago